Mike Leyland is a widely experienced, senior finance executive specialising in guiding early biotech start-up companies.

Mike graduated from Kings College London with a degree in Chemistry, before taking an assistant manager’s position at Thomson McLintock & Co (now part of KPMG). After qualifying as a Chartered Accountant, he moved to British Leyland Truck and Bus to take up a position as Financial Accounting Manager. He then moved to Glaxo where he worked for 16 years in a variety of senior positions including FD for Glaxo Export Ltd, FD Glaxo Companies Singapore, Director of Administration at their research base in Geneva and Group Deputy Treasurer. He also served as a non-executive director for Glaxo India, their Mumbai quoted business.

After he left Glaxo, Mike helped establish Pappas Ventures at Research Triangle Park, North Carolina and then has worked with UK early-stage biotech businesses.

Now semi-retired, Mike brings a wealth of Board expertise to Biostatus, both as an executive and non-executive director of OFEX and other private companies and major subsidiaries of Glaxo world-wide. He is a valuable member of the Biostatus team offering financial and strategic support to the company.